Christopher M. Kramer

3 weeks ago | jacc.org | Milton Packer |Michael R. Zile |Christopher M. Kramer |Masahiro Murakami

References1. "Predictors of new-onset heart failure: differences in preserved versus reduced ejection fraction". Circ Heart Fail . 2013;6:279-286. 2. "The association of obesity and cardiometabolic traits with incident HFpEF and HFrEF". JACC Heart Fail . 2018;6:701-709. 3. "Evidence supporting the existence of a distinct obese phenotype of heart failure with preserved ejection fraction". Circulation . 2017;136:6-19. 4.

Nov 21, 2024 | businesswire.com | Christopher M. Kramer

Consortium will seek to increase the supply diversity of electric vehicle batteries and relieve supply chain concerns

Nov 17, 2024 | healio.com | Erik Swain |Richard Smith |Christopher M. Kramer |Sanjit S. Jolly

Christopher M. Kramer, MD The large, double-blind, 2x2 factorial study showed that neither colchicine nor spironolactone were beneficial in the acute MI population. I am not necessarily surprised by the spironolactone results. If these patients don’t have frank HF, they may have asymptomatic LV dysfunction, and they are well-treated with other medications such as ACE inhibitors and statins.

Jul 21, 2024 | bdoutdoors.com | Christopher M. Kramer

#1I recently received a seeker osp 3x as a gift. Pretty sick rod. I'm thinking about putting an avet XHW 5/2 Raptor on it. I want to put 130 lb hollow braid. I will be using it for 100lb to 300lb tuna . Does this sound appropriate to you guys. #2The difference between 100-150lb fish and 200-300 can be night and day. Your rig will work great, but will feel oversized at the bottom end and possibly undersized at the top.

Apr 6, 2024 | jacc.org | Christopher M. Kramer |Milton Packer |Subodh Verma |A. Michael Lincoff

SUMMIT 2024: A Video Interview With Harlan Krumholz and Milton Packer Obesity Trials Collection at JACC SUMMIT SELECT STEP-HFpEF FLOW A Study of Tirzepatide in Participants with Heart Failure with Preserved Ejection Fraction (HFpEF) and Obesity. Semaglutide Effects on Cardiovascular Outcomes in People with Overweight or Obesity. Semaglutide Treatment Effect in People with Obesity and Heart Failure with Preserved Ejection Fraction.